Diaphorina citri psyllid: psy15050

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320---
MSPAIAPTIQLNNGQEIPALGLGTWQGEPGSGDVKNAVLAAIDAGYRHIDTAEVYQTEGDIGEAIKEKINSGDIKREELFITTKVWITHFEPDMVVQACQNSCKKLGLDYVDLYLIHWPFAIKGKDVHDTSFEGEHNNVSIEETWRGMEKCVEKGLAKSIGVSNFNSGQIKRILDCAKIKPVNLQIEVHPYLNQRKLIDFCKKHNITVTAYSPLGAPWTNPDKPLLINDDVLKEIADKYRKSPAQVVLRYLVFLMVCRLSSGEHKVFVEQGSPTEEHAIQSYSHLPGELSNVCFTSQYDTTSGLSVRGTLVKLLQMFLRVTYG
cccccccEEEccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHcccccccccEEEcccccccccccHHHHHHHHHHHHHccccccccEECcccccccccccccccccccccccHHHHHHHHHHHHHcccEEEEEEccccHHHHHHHHHcccccccccccccccccccHHHHHHHHHcccEEEEEccccccccccccccccccHHHHHHHHHHcccHHHHHHHHHHccccEEEcccccHHHHHccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccc
*****AP*IQLNNGQEIPALGLGTWQGEPGSGDVKNAVLAAIDAGYRHIDTAEVYQTEGDIGEAIKEKINSGDIKREELFITTKVWITHFEPDMVVQACQNSCKKLGLDYVDLYLIHWPFAIKGKDVHDTSFEGEHNNVSIEETWRGMEKCVEKGLAKSIGVSNFNSGQIKRILDCAKIKPVNLQIEVHPYLNQRKLIDFCKKHNITVTAYSPLGAPWTNPDKPLLINDDVLKEIADKYRKSPAQVVLRYLVFLMVCRLSSGEHKVFVEQGSPTEEHAIQSYSHLPGELSNVCFTSQYDTTSGLSVRGTLVKLLQMFLRVTYG
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MSPAIAPTIQLNNGQEIPALGLGTWQGEPGSGDVKNAVLAAIDAGYRHIDTAEVYQTEGDIGEAIKEKINSGDIKREELFITTKVWITHFEPDMVVQACQNSCKKLGLDYVDLYLIHWPFAIKGKDVHDTSFEGEHNNVSIEETWRGMEKCVEKGLAKSIGVSNFNSGQIKRILDCAKIKPVNLQIEVHPYLNQRKLIDFCKKHNITVTAYSPLGAPWTNPDKPLLINDDVLKEIADKYRKSPAQVVLRYLVFLMVCRLSSGEHKVFVEQGSPTEEHAIQSYSHLPGELSNVCFTSQYDTTSGLSVRGTLVKLLQMFLRVTYG

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Alcohol dehydrogenase [NADP(+)] Catalyzes the NADPH-dependent reduction of a variety of aromatic and aliphatic aldehydes to their corresponding alcohols. Catalyzes the reduction of mevaldate to mevalonic acid and of glyceraldehyde to glycerol. Has broad substrate specificity. In vitro substrates include succinic semialdehyde, 4-nitrobenzaldehyde, 1,2-naphthoquinone, methylglyoxal, and D-glucuronic acid. Plays a role in the activation of procarcinogens, such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in the metabolism of various xenobiotics and drugs, including the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN).confidentP14550
Aldose reductase B Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies.confidentQ54NZ7
Aldo-keto reductase family 4 member C10 Oxidoreductase that may act on a broad range of substrates such as ketosteroids, aldehydes, ketones and sugars.confidentQ84TF0

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0047042 [MF]androsterone dehydrogenase (B-specific) activityprobableGO:0016229, GO:0016614, GO:0016616, GO:0033764, GO:0003824, GO:0003674, GO:0047023, GO:0016491
GO:0047115 [MF]trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activityprobableGO:0003824, GO:0016627, GO:0003674, GO:0016628, GO:0016491
GO:0001758 [MF]retinal dehydrogenase activityprobableGO:0003824, GO:0016903, GO:0003674, GO:0016620, GO:0016491
GO:0016655 [MF]oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptorprobableGO:0003824, GO:0003674, GO:0016651, GO:0016491
GO:0006693 [BP]prostaglandin metabolic processprobableGO:0044238, GO:0006631, GO:0006629, GO:0006082, GO:0071704, GO:1901568, GO:0009987, GO:0044710, GO:0019752, GO:0032787, GO:0006690, GO:0006692, GO:0008150, GO:0044237, GO:0008152, GO:0043436, GO:0044255, GO:0033559, GO:0044281
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0070401 [MF]NADP+ bindingprobableGO:0043168, GO:0050662, GO:0050661, GO:0097159, GO:0000166, GO:0036094, GO:0048037, GO:0005488, GO:0003674, GO:0043167, GO:1901363, GO:1901265
GO:0042448 [BP]progesterone metabolic processprobableGO:0042445, GO:0044710, GO:0065008, GO:0042180, GO:0044238, GO:1901360, GO:0009987, GO:0044237, GO:0010817, GO:0071704, GO:0008150, GO:0044281, GO:0008152, GO:0065007, GO:0008207, GO:0034754, GO:0008202, GO:0006629
GO:0047036 [MF]codeinone reductase (NADPH) activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:0005829 [CC]cytosolprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0004032 [MF]alditol:NADP+ 1-oxidoreductase activityprobableGO:0004033, GO:0008106, GO:0016614, GO:0016616, GO:0003824, GO:0003674, GO:0016491
GO:0007186 [BP]G-protein coupled receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0050789, GO:0044699
GO:0071395 [BP]cellular response to jasmonic acid stimulusprobableGO:1901700, GO:1901701, GO:0051716, GO:0009753, GO:0009725, GO:0050896, GO:0009987, GO:0071310, GO:0009719, GO:0071495, GO:0032870, GO:0044763, GO:0008150, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0047086 [MF]ketosteroid monooxygenase activityprobableGO:0004497, GO:0016709, GO:0016705, GO:0003824, GO:0003674, GO:0016491
GO:0004958 [MF]prostaglandin F receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0004953, GO:0004954, GO:0004955, GO:0004871, GO:0003674, GO:0004872
GO:0055114 [BP]oxidation-reduction processprobableGO:0044710, GO:0008150, GO:0008152
GO:0042574 [BP]retinal metabolic processprobableGO:0044238, GO:0044710, GO:0006081, GO:0006721, GO:0006720, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152, GO:0016101, GO:0044255, GO:0001523, GO:0006629
GO:0032052 [MF]bile acid bindingprobableGO:0043168, GO:0097159, GO:0031406, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0005496, GO:0033293
GO:0051260 [BP]protein homooligomerizationprobableGO:0051259, GO:0022607, GO:0071822, GO:0070271, GO:0043933, GO:0006461, GO:0016043, GO:0065003, GO:0044085, GO:0008150, GO:0071840
GO:0051897 [BP]positive regulation of protein kinase B signaling cascadeprobableGO:0023051, GO:0009966, GO:0010740, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0050789, GO:0065007, GO:0009967, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0010627, GO:0051896, GO:0048522
GO:0018636 [MF]phenanthrene 9,10-monooxygenase activityprobableGO:0004497, GO:0016709, GO:0016705, GO:0003824, GO:0003674, GO:0016491
GO:0008206 [BP]bile acid metabolic processprobableGO:0044238, GO:0044710, GO:0006629, GO:0006082, GO:0044237, GO:0009987, GO:0019752, GO:0032787, GO:0071704, GO:0008150, GO:0008202, GO:0008152, GO:0043436, GO:1901360, GO:0044281
GO:0047045 [MF]testosterone 17-beta-dehydrogenase (NADP+) activityprobableGO:0016229, GO:0016614, GO:0016616, GO:0033764, GO:0003824, GO:0003674, GO:0016491
GO:0019853 [BP]L-ascorbic acid biosynthetic processprobableGO:0046364, GO:0019752, GO:0016053, GO:0043436, GO:0044281, GO:0044283, GO:0019852, GO:0044710, GO:0044711, GO:0071704, GO:0006767, GO:0006766, GO:1901576, GO:0009987, GO:0009058, GO:0009110, GO:0008150, GO:0008152, GO:0044723, GO:0044238, GO:0005975, GO:0006082, GO:0044249, GO:0046394, GO:0005996, GO:0042364, GO:0044237, GO:0016051
GO:0047939 [MF]L-glucuronate reductase activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:0030299 [BP]intestinal cholesterol absorptionprobableGO:0051234, GO:0032501, GO:0022600, GO:0044707, GO:0015918, GO:0015850, GO:0007586, GO:0006869, GO:0050892, GO:0030301, GO:0044765, GO:0008150, GO:0006810, GO:0071702, GO:0044241, GO:0033036, GO:0010876, GO:0051179, GO:0044699, GO:0003008
GO:0004090 [MF]carbonyl reductase (NADPH) activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:2000379 [BP]positive regulation of reactive oxygen species metabolic processprobableGO:0009893, GO:0019222, GO:0031325, GO:0031323, GO:2000377, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:1901869 [BP]ecgonine methyl ester biosynthetic processprobableGO:0044249, GO:0034641, GO:0006807, GO:1901362, GO:1901360, GO:1901576, GO:0009821, GO:0009820, GO:0009710, GO:0071704, GO:0046448, GO:0018130, GO:1901867, GO:0009987, GO:0009058, GO:0008150, GO:0008152, GO:1901564, GO:0046483, GO:0044271, GO:1901566, GO:0044237
GO:0047006 [MF]17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activityprobableGO:0016229, GO:0016614, GO:0016616, GO:0033764, GO:0003824, GO:0003674, GO:0016491
GO:0048385 [BP]regulation of retinoic acid receptor signaling pathwayprobableGO:0009966, GO:0048583, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0050789
GO:0044597 [BP]daunorubicin metabolic processprobableGO:0016137, GO:0071704, GO:1901135, GO:0044710, GO:1901657, GO:0008150, GO:0008152, GO:0030647
GO:0044598 [BP]doxorubicin metabolic processprobableGO:0016137, GO:0071704, GO:0044710, GO:1901657, GO:0008150, GO:0008152
GO:0016324 [CC]apical plasma membraneprobableGO:0045177, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0006973 [BP]intracellular accumulation of glycerolprobableGO:0019725, GO:0009628, GO:0051716, GO:0071214, GO:0033554, GO:0050896, GO:0071470, GO:0071474, GO:0042592, GO:0006950, GO:0065007, GO:0044763, GO:0008150, GO:0006972, GO:0006970, GO:0009987, GO:0065008, GO:0044699
GO:0004745 [MF]retinol dehydrogenase activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:0019568 [BP]arabinose catabolic processprobableGO:0019321, GO:0044238, GO:0019323, GO:0005975, GO:0046365, GO:0005996, GO:0016052, GO:0019566, GO:0071704, GO:0008150, GO:0008152, GO:1901575, GO:0044723, GO:0009056, GO:0044724
GO:0005615 [CC]extracellular spaceprobableGO:0005575, GO:0005576, GO:0044421
GO:0044767 [BP]single-organism developmental processprobableGO:0032502, GO:0008150, GO:0044699
GO:0015721 [BP]bile acid and bile salt transportprobableGO:0015718, GO:0015849, GO:0006811, GO:0006810, GO:0015711, GO:0044765, GO:0006820, GO:0008150, GO:0071702, GO:0051234, GO:0051179, GO:0044699, GO:0046942
GO:0046683 [BP]response to organophosphorusprobableGO:0042221, GO:0050896, GO:0008150, GO:0010033
GO:0006707 [BP]cholesterol catabolic processprobableGO:0044281, GO:0044282, GO:1901360, GO:0006629, GO:0044712, GO:1901575, GO:0016042, GO:0071704, GO:1901361, GO:0016127, GO:0016125, GO:0006706, GO:0046164, GO:0044710, GO:0008150, GO:0008152, GO:0009056, GO:0008202, GO:0008203, GO:0044238, GO:0006066, GO:1901616, GO:1901615
GO:0071379 [BP]cellular response to prostaglandin stimulusprobableGO:0071495, GO:1901701, GO:0071398, GO:0051716, GO:0008150, GO:0009725, GO:0070542, GO:0009987, GO:0071396, GO:0071310, GO:0009719, GO:0050896, GO:0044763, GO:0032870, GO:0034694, GO:1901700, GO:0070887, GO:0033993, GO:0042221, GO:0010033, GO:0044699
GO:0047718 [MF]indanol dehydrogenase activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:0047568 [MF]3-oxo-5-beta-steroid 4-dehydrogenase activityprobableGO:0016229, GO:0016627, GO:0033765, GO:0003824, GO:0003674, GO:0016491
GO:0051269 [MF]alpha-keto ester reductase activityprobableGO:0003824, GO:0016903, GO:0003674, GO:0016491
GO:0042493 [BP]response to drugprobableGO:0042221, GO:0050896, GO:0008150
GO:0035410 [MF]dihydrotestosterone 17-beta-dehydrogenase activityprobableGO:0016229, GO:0016614, GO:0016616, GO:0033764, GO:0003824, GO:0003674, GO:0016491
GO:0000060 [BP]protein import into nucleus, translocationprobableGO:0034504, GO:0051169, GO:0008104, GO:0044699, GO:0070727, GO:0006886, GO:0071702, GO:0051641, GO:0034613, GO:0017038, GO:0006810, GO:0006606, GO:0006913, GO:0006605, GO:0045184, GO:0015031, GO:0044765, GO:0051170, GO:0051649, GO:0044744, GO:0051234, GO:0051179, GO:0016482, GO:0033036, GO:0046907, GO:0044763, GO:0033365, GO:0008150, GO:0009987
GO:0072330 [BP]monocarboxylic acid biosynthetic processprobableGO:1901576, GO:0044710, GO:0044711, GO:0006082, GO:0071704, GO:0046394, GO:0044237, GO:0009987, GO:0016053, GO:0019752, GO:0032787, GO:0044249, GO:0009058, GO:0008150, GO:0044281, GO:0008152, GO:0044283, GO:0043436
GO:0045703 [MF]ketoreductase activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016491
GO:0046185 [BP]aldehyde catabolic processprobableGO:1901575, GO:0006081, GO:0009987, GO:0044710, GO:0044237, GO:0044248, GO:0071704, GO:0008150, GO:0008152, GO:0009056
GO:0070402 [MF]NADPH bindingprobableGO:0043168, GO:0050662, GO:0050661, GO:0097159, GO:0000166, GO:0036094, GO:0048037, GO:0005488, GO:0003674, GO:0043167, GO:1901363, GO:1901265
GO:0022414 [BP]reproductive processprobableGO:0008150, GO:0000003
GO:0043627 [BP]response to estrogen stimulusprobableGO:0009719, GO:0033993, GO:0050896, GO:0008150, GO:0048545, GO:0009725, GO:0042221, GO:0010033, GO:0014070
GO:0040011 [BP]locomotionprobableGO:0008150
GO:0048513 [BP]organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0045550 [MF]geranylgeranyl reductase activityprobableGO:0003824, GO:0003674, GO:0016491
GO:0047020 [MF]15-hydroxyprostaglandin-D dehydrogenase (NADP+) activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:0004303 [MF]estradiol 17-beta-dehydrogenase activityprobableGO:0016229, GO:0016614, GO:0016616, GO:0033764, GO:0003824, GO:0003674, GO:0016491
GO:1901868 [BP]ecgonine methyl ester catabolic processprobableGO:1901575, GO:0044270, GO:1901564, GO:0009822, GO:1901867, GO:0009820, GO:0009987, GO:0044237, GO:0046700, GO:0044248, GO:0071704, GO:0034641, GO:1901565, GO:0006807, GO:0008152, GO:0046448, GO:0008150, GO:0046483, GO:0009056, GO:1901360, GO:1901361
GO:0045335 [CC]phagocytic vesicleprobableGO:0005737, GO:0005575, GO:0043231, GO:0016023, GO:0031410, GO:0044464, GO:0044444, GO:0005623, GO:0031988, GO:0030139, GO:0043229, GO:0044424, GO:0005622, GO:0043227, GO:0043226, GO:0031982
GO:0052650 [MF]NADP-retinol dehydrogenase activityprobableGO:0004033, GO:0008106, GO:0016614, GO:0016616, GO:0003824, GO:0003674, GO:0016491
GO:0042572 [BP]retinol metabolic processprobableGO:0042445, GO:0044710, GO:0065008, GO:0006629, GO:0044238, GO:0006721, GO:0006720, GO:0009987, GO:0044237, GO:0001523, GO:0071704, GO:0065007, GO:0008150, GO:0008152, GO:0016101, GO:0044255, GO:0010817, GO:0034754
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0005739 [CC]mitochondrionprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0006725 [BP]cellular aromatic compound metabolic processprobableGO:0009987, GO:0008150, GO:0008152, GO:0044237
GO:2000353 [BP]positive regulation of endothelial cell apoptotic processprobableGO:0050789, GO:2000351, GO:0050794, GO:0043065, GO:0048518, GO:0043067, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0016488 [BP]farnesol catabolic processprobableGO:0006714, GO:0044248, GO:0034310, GO:0044281, GO:0044282, GO:0044242, GO:0034308, GO:0044712, GO:1901575, GO:0016042, GO:0071704, GO:0016107, GO:0009987, GO:0006629, GO:0006721, GO:0006720, GO:0046164, GO:0044710, GO:0008150, GO:0008300, GO:0008152, GO:0044255, GO:0009056, GO:0044238, GO:1901616, GO:0044237, GO:0006066, GO:0016115, GO:0016487, GO:1901615
GO:0071384 [BP]cellular response to corticosteroid stimulusprobableGO:0071495, GO:0033993, GO:0051716, GO:0009719, GO:0008150, GO:0031960, GO:0071383, GO:0009987, GO:0071396, GO:0071310, GO:0044699, GO:0009725, GO:0050896, GO:0032870, GO:0044763, GO:0014070, GO:0070887, GO:0071407, GO:0042221, GO:0010033, GO:0048545
GO:0034614 [BP]cellular response to reactive oxygen speciesprobableGO:1901700, GO:1901701, GO:0051716, GO:0070887, GO:0050896, GO:0009987, GO:0000302, GO:0008150, GO:0006950, GO:0044763, GO:0033554, GO:0042221, GO:0034599, GO:0006979, GO:0044699
GO:0009507 [CC]chloroplastprobableGO:0005737, GO:0009536, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0043795 [MF]glyceraldehyde oxidoreductase activityprobableGO:0003824, GO:0016903, GO:0003674, GO:0016491
GO:0016918 [MF]retinal bindingprobableGO:0019840, GO:0008289, GO:0019842, GO:0036094, GO:0003674, GO:0005488, GO:0005501
GO:0042840 [BP]D-glucuronate catabolic processprobableGO:0046365, GO:0019752, GO:0044248, GO:0043436, GO:0044281, GO:0044282, GO:0044712, GO:1901575, GO:0071704, GO:0019585, GO:0009987, GO:0044710, GO:0032787, GO:0008150, GO:0008152, GO:0072329, GO:0044723, GO:0009056, GO:0044724, GO:0044238, GO:0005975, GO:0006082, GO:0046395, GO:0016054, GO:0016052, GO:0044237, GO:0042839, GO:0006064, GO:0006063, GO:0005996
GO:0042843 [BP]D-xylose catabolic processprobableGO:0042732, GO:0019321, GO:0019323, GO:0005975, GO:0044238, GO:0046365, GO:0005996, GO:0016052, GO:1901575, GO:0071704, GO:0008150, GO:0008152, GO:0044723, GO:0009056, GO:0044724
GO:1901872 [BP]ecgonone methyl ester biosynthetic processprobableGO:1901870, GO:0044249, GO:0034641, GO:0006807, GO:0044281, GO:0044283, GO:1901362, GO:1901360, GO:1901576, GO:0044710, GO:0044711, GO:0009821, GO:0009820, GO:0009710, GO:0071704, GO:0046448, GO:0018130, GO:0009987, GO:0009058, GO:0008150, GO:0008152, GO:0044271, GO:0046483, GO:1901564, GO:0042181, GO:0042180, GO:1901566, GO:0044237
GO:1901871 [BP]ecgonone methyl ester catabolic processprobableGO:1901870, GO:0044248, GO:0034641, GO:0006807, GO:0044281, GO:0044282, GO:1901360, GO:1901361, GO:0044712, GO:1901575, GO:0009822, GO:0009820, GO:0071704, GO:0046448, GO:0046483, GO:0009987, GO:0044710, GO:0046700, GO:0008150, GO:0008152, GO:0009056, GO:0042180, GO:1901564, GO:0044270, GO:0042182, GO:0044237, GO:1901565
GO:0047011 [MF]2-dehydropantolactone reductase (A-specific) activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:0071277 [BP]cellular response to calcium ionprobableGO:0051716, GO:0071248, GO:0010038, GO:0050896, GO:0009987, GO:0071241, GO:0051592, GO:0044763, GO:0008150, GO:0070887, GO:0042221, GO:0010035, GO:0044699
GO:0071276 [BP]cellular response to cadmium ionprobableGO:0051716, GO:0071248, GO:0010038, GO:0050896, GO:0009987, GO:0071241, GO:0008150, GO:0044763, GO:0070887, GO:0046686, GO:0042221, GO:0010035, GO:0044699
GO:0009055 [MF]electron carrier activityprobableGO:0003674
GO:0042632 [BP]cholesterol homeostasisprobableGO:0042592, GO:0048878, GO:0055088, GO:0065007, GO:0008150, GO:0065008, GO:0055092
GO:0047787 [MF]delta4-3-oxosteroid 5beta-reductase activityprobableGO:0016628, GO:0016627, GO:0003824, GO:0003674, GO:0035671, GO:0016491
GO:1900053 [BP]negative regulation of retinoic acid biosynthetic processprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0046890, GO:0046137, GO:0050789, GO:0019222, GO:0032351, GO:0032350, GO:0010565, GO:0045833, GO:0065007, GO:0048519, GO:0051055, GO:0019747, GO:0019216, GO:0009889, GO:0050794, GO:0008150, GO:0030656, GO:1900052, GO:0045827, GO:0048523
GO:0009651 [BP]response to salt stressprobableGO:0008150, GO:0009628, GO:0006950, GO:0006970, GO:0050896
GO:0061370 [BP]testosterone biosynthetic processprobableGO:0044249, GO:0044281, GO:0044283, GO:1901362, GO:1901360, GO:1901576, GO:0042446, GO:0044711, GO:0071704, GO:0065007, GO:0065008, GO:0006702, GO:0006629, GO:0042445, GO:0046165, GO:0009987, GO:0044710, GO:0010817, GO:0009058, GO:0008150, GO:0008209, GO:0008152, GO:0034754, GO:0008202, GO:0008610, GO:0044238, GO:0042181, GO:0042180, GO:0044237, GO:0006066, GO:0006694, GO:1901617, GO:1901615
GO:0043603 [BP]cellular amide metabolic processprobableGO:0009987, GO:0044237, GO:0034641, GO:0006807, GO:0008150, GO:0008152
GO:0003729 [MF]mRNA bindingprobableGO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:1901363, GO:0003723
GO:0019751 [BP]polyol metabolic processprobableGO:0044710, GO:0006066, GO:0071704, GO:0008150, GO:0044281, GO:0008152, GO:1901615
GO:0051268 [MF]alpha-keto amide reductase activityprobableGO:0003824, GO:0016903, GO:0003674, GO:0016491
GO:0047935 [MF]glucose 1-dehydrogenase (NADP+) activityprobableGO:0003824, GO:0003674, GO:0016614, GO:0016616, GO:0016491
GO:2000224 [BP]regulation of testosterone biosynthetic processprobableGO:0009889, GO:0019222, GO:0019216, GO:0032350, GO:0031326, GO:0046890, GO:0031323, GO:0010565, GO:0010566, GO:0050794, GO:0008150, GO:0050810, GO:0046885, GO:0019218, GO:0065007, GO:0050789, GO:0080090

Prediction of Enzyme Commission Number ?

EC Number ?Description ?Confidence Level ?
1.-.-.-Oxidoreductases.probable
1.1.-.-Acting on the CH-OH group of donors.probable
1.1.1.-15-hydroxyprostaglandin dehydrogenase (NAD(+)).probable

Spatial Structural Prediction

Structural Models Based on Templates

Template: 1S1P, chain A
Confidence level:very confident
Coverage over the Query: 7-286
View the alignment between query and template
View the model in PyMOL